These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32725604)

  • 41. Outpatient Renal Function Screening Before Contrast-Enhanced CT Examinations.
    Lee Y; Hwang I; Cho YJ; Han SS; Yoon SH
    J Korean Med Sci; 2024 Oct; 39(38):e298. PubMed ID: 39376193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dosing of iodinated contrast volume: a new simple algorithm to stratify the risk of contrast-induced nephropathy in patients with acute coronary syndrome.
    Raposeiras-Roubín S; Abu-Assi E; Ocaranza-Sánchez R; Alvarez-Álvarez B; Cambeiro-González C; Fandiño-Vaquero R; García-Castelo A; García-Acuña JM; González-Juanatey JR
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):888-97. PubMed ID: 23362013
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of renal dysfunction by point-of-care creatinine testing in patients undergoing peripheral MR angiography.
    Kalisz KR; Davarpanah AH; Usman AA; Collins JD; Carroll TJ; Carr JC
    AJR Am J Roentgenol; 2011 Aug; 197(2):430-5. PubMed ID: 21785090
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is there association between statin usage and contrast-associated acute kidney injury after intravenous administration of iodine-based contrast media in enhanced computed tomography?
    Park JH; Shin HJ; Choi JY; Lim JS; Park MS; Kim MJ; Oh HJ; Chung YE
    Eur Radiol; 2020 Oct; 30(10):5261-5271. PubMed ID: 32399711
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Creatinine-based estimation of glomerular filtration rate in patients with a Fontan circulation.
    Wilson TG; d'Udekem Y; Winlaw DS; Cordina RL; Ayer J; Gentles TL; Weintraub RG; Grigg LE; Cheung M; Cain TM; Rao P; Verrall C; Plessis KD; Rice K; Iyengar AJ
    Congenit Heart Dis; 2019 May; 14(3):454-463. PubMed ID: 30664330
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improving NSAIDs Prescription in Emergency Services Unit by a Point-of-Care-Based Renal Function Evaluation.
    Blairon L; Abbasi M; Beukinga I; Melot C; Libertalis M
    J Emerg Med; 2020 Mar; 58(3):481-486. PubMed ID: 31843321
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Application of a point of care creatinine device for trend monitoring in kidney transplant patients: fit for purpose?
    van Lint CL; van der Boog PJ; Romijn FP; Schenk PW; van Dijk S; Rövekamp TJ; Kessler A; Siekmann L; Rabelink TJ; Cobbaert CM
    Clin Chem Lab Med; 2015 Sep; 53(10):1547-56. PubMed ID: 25719331
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence of contrast-induced acute kidney injury (CI-AKI) in high-risk oncology patients undergoing contrast-enhanced CT with a reduced dose of the iso-osmolar iodinated contrast medium iodixanol.
    Werner S; Bez C; Hinterleitner C; Horger M
    PLoS One; 2020; 15(5):e0233433. PubMed ID: 32437415
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Background fluctuation of kidney function versus contrast-induced nephrotoxicity.
    Bruce RJ; Djamali A; Shinki K; Michel SJ; Fine JP; Pozniak MA
    AJR Am J Roentgenol; 2009 Mar; 192(3):711-8. PubMed ID: 19234268
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prediction of presence of kidney disease in a general patient population undergoing intravenous iodinated contrast enhanced computed tomography.
    Moos SI; Stoker J; Nagan G; de Weijert RS; van Vemde DN; Bipat S
    Eur Radiol; 2014 Jun; 24(6):1266-75. PubMed ID: 24663822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Iodinated contrast media and nephropathy. Estimated creatinine clearance for better assessment of renal function and dosage].
    Nyman U; Hietala SO; Hellström M; Aspelin P; Björkdahl P; Albrechtsson U; Magnusson A; Måre K; Törnquist C; Ringertz H; Sterner G; Westberg G; Berne C
    Ugeskr Laeger; 2004 Jun; 166(26-31):2566-72. PubMed ID: 15285166
    [No Abstract]   [Full Text] [Related]  

  • 52. [Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial].
    Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; van Ommen V; Wildberger JE
    Ned Tijdschr Geneeskd; 2018; 161():D1734. PubMed ID: 29328007
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contrast volume to estimated glomerular filtration rate ratio for prediction of contrast-induced acute kidney injury after cardiac catheterization in adults with congenital heart disease.
    Gellis L; Gauvreau K; Ferguson M; Bergersen L; Shafer K; Porras D
    Catheter Cardiovasc Interv; 2018 Dec; 92(7):1301-1308. PubMed ID: 30196559
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low incidence of nephrotoxicity following intravenous administration of iodinated contrast media: a prospective study.
    Castaldo P; Frascà GM; Brigante F; Ferrante L; Magi S; Pavani M; Skrami E; Giuseppetti GM; Polonara G; Amoroso S
    Eur Radiol; 2019 Jul; 29(7):3927-3934. PubMed ID: 30989349
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study.
    Akrawinthawong K; Ricci J; Cannon L; Dixon S; Kupfer K; Stivers D; Alexander P; David S; McCullough PA
    Ren Fail; 2015 Mar; 37(2):187-91. PubMed ID: 25519207
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The evaluation of creatinine clearance, estimated glomerular filtration rate and serum creatinine in predicting contrast-induced acute kidney injury among patients undergoing percutaneous coronary intervention.
    Robert AM; Brown JR; Sidhu MS; Ramanath VS; Devries JT; Jayne JE; Hettleman BD; Friedman BJ; Niles NW; Kaplan AV; Malenka DJ; Robb JF; Thompson CA;
    Cardiovasc Revasc Med; 2012; 13(1):3-10. PubMed ID: 22093591
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glomerular filtration rate in evaluation of the effect of iodinated contrast media on renal function.
    Becker J; Babb J; Serrano M
    AJR Am J Roentgenol; 2013 Apr; 200(4):822-6. PubMed ID: 23521455
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Point-of-Care Testing in Chronic Kidney Disease of Non-Traditional Origin: Considerations for Clinical, Epidemiological, and Health Surveillance Research and Practice.
    Dally M; Amador JJ; Butler-Dawson J; Lopez-Pilarte D; Gero A; Krisher L; Cruz A; Pilloni D; Kupferman J; Friedman DJ; Griffin BR; Newman LS; Brooks DR
    Ann Glob Health; 2023; 89(1):7. PubMed ID: 36789382
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk of Acute Kidney Injury, Dialysis, and Mortality in Patients With Chronic Kidney Disease After Intravenous Contrast Material Exposure.
    McDonald JS; McDonald RJ; Lieske JC; Carter RE; Katzberg RW; Williamson EE; Kallmes DF
    Mayo Clin Proc; 2015 Aug; 90(8):1046-53. PubMed ID: 26250726
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of point-of-care pre-procedure creatinine and eGFR testing in patients with ST segment elevation myocardial infarction undergoing primary PCI: The pilot STATCREAT study.
    Karamasis GV; Hampton-Till J; Al-Janabi F; Mohdnazri S; Parker M; Ioannou A; Jagathesan R; Kabir A; Sayer JW; Robinson NM; Aggarwal RK; Clesham GJ; Gamma RA; Kelly PA; Tang KH; Davies JR; Keeble T
    Int J Cardiol; 2017 Aug; 240():8-13. PubMed ID: 28400120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.